Resistance to chemotherapeutic treatments is caused in glioma cells by the production of SGs via eIF2α phosphorylation.Inhibition of eIF2α phosphorylation and SG formation results in enhanced susceptibility to chemotherapeutic drugs. The gene discussed is EIF2A; the disease is central nervous system cancer.